Dongbang Medical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	113,537	105,114	90,875	81,408
Revenue Growth (YoY)	8.01%	15.67%	11.63%	-
Cost of Revenue	73,394	71,020	60,134	58,887
Gross Profit	40,143	34,094	30,741	22,520
Selling, General & Admin	18,137	14,821	11,972	11,240
Research & Development	3,287	2,591	2,100	1,798
Amortization of Goodwill & Intangibles	254.1	252.13	241.12	370.93
Other Operating Expenses	534.74	361.01	286.9	572.2
Operating Expenses	23,891	18,618	13,560	16,961
Operating Income	16,252	15,476	17,182	5,560
Interest Expense	-1,137	-1,956	-2,613	-1,308
Interest & Investment Income	404.75	201.48	86.23	40.72
Earnings From Equity Investments	-	-	45.53	-
Currency Exchange Gain (Loss)	-188.94	1,080	-202.05	734.38
Other Non Operating Income (Expenses)	225.63	-9,270	-1,182	1,159
EBT Excluding Unusual Items	15,556	5,532	13,317	6,186
Gain (Loss) on Sale of Investments	-1,455	-727.67	-709.31	-537.95
Gain (Loss) on Sale of Assets	181.98	1,986	-102.65	-28.47
Pretax Income	14,283	6,791	12,505	5,619
Income Tax Expense	2,840	3,663	2,771	2,300
Earnings From Continuing Operations	11,442	3,127	9,734	3,320
Minority Interest in Earnings	260.91	-212.84	40.46	-127.95
Net Income	11,703	2,914	9,775	3,192
Net Income to Common	11,703	2,914	9,775	3,192
Net Income Growth	301.58%	-70.19%	206.26%	-
Shares Outstanding (Basic)	20	16	15	15
Shares Outstanding (Diluted)	21	16	17	15
Shares Change (YoY)	28.29%	-7.51%	17.90%	-
EPS (Basic)	572.40	180.07	658.62	215.05
EPS (Diluted)	564.00	180.07	617.82	215.05
EPS Growth	213.20%	-70.85%	187.29%	-
Free Cash Flow	-2,505	5,408	1,811	4,379
Free Cash Flow Per Share	-120.64	334.19	103.53	295.08
Gross Margin	35.36%	32.44%	33.83%	27.66%
Operating Margin	14.31%	14.72%	18.91%	6.83%
Profit Margin	10.31%	2.77%	10.76%	3.92%
Free Cash Flow Margin	-2.21%	5.15%	1.99%	5.38%
EBITDA	23,273	21,640	22,630	10,832
EBITDA Margin	20.50%	20.59%	24.90%	13.31%
D&A For EBITDA	7,021	6,164	5,448	5,272
EBIT	16,252	15,476	17,182	5,560
EBIT Margin	14.31%	14.72%	18.91%	6.83%
Effective Tax Rate	19.89%	53.95%	22.16%	40.92%
Advertising Expenses	1,944	1,446	994.74	482.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.